Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

UTI Nifty Midcap 150 Exchange Traded Fund · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseUTINippon India
NAV₹230.3012₹29.1863
NAV date20 Nov 202620 Nov 2026
History3.2 years5.4 years
Expense ratio0.0%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
1 month+5.92%+10.82%
3 months−2.60%+7.43%
6 months+1.69%+14.54%
YTD+2.62%+25.40%
1 year+2.02%+25.57%
3 years (CAGR)+13.88%+22.02%
5 years (CAGR)—+16.60%
10 years (CAGR)——
Since launch+14.70%+14.02%

Risk

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
Volatility18.3%15.0%
Downside volatility12.5%9.0%
Sharpe0.401.04
Sortino0.591.72
Calmar0.661.33
Return / risk0.761.47
Deepest fall−20.98%−20.98%
Days to recover262136
Below its high−3.25%−1.75%

Against benchmark

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
Alpha+0.01%+0.00%
Beta1.001.00
R²100.0%100.0%
Up capture100.1%100.0%
Down capture100.2%100.0%
Tracking error0.1%0.0%
Information ratio0.19—
Treynor0.060.14

Consistency

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
Best 1-year+50.21%+65.21%
Middle 1-year+7.49%+13.46%
Worst 1-year−5.89%−15.30%
1-year periods with a loss12.4%25.8%
Middle 3-year+13.87%+20.51%
Positive months66.7%61.1%
Best day+3.97%+3.64%
Worst day−7.11%−4.03%
Worst 5% day−2.00%−1.62%
Positive days57.2%54.4%
NAVs a year248248

SIP of ₹10,000 a month

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
5-year XIRR—+20.60%
5-year value—₹10,11,738
3-year XIRR+7.86%+19.58%
1-year XIRR+6.12%+34.31%

Holdings overlap i

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
UTI Nifty Midcap 150 Exchange Traded Fund—9%
Nippon India Nifty Pharma ETF9%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockUTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
Laurus Labs Limited2.39%9.26%
Lupin Limited1.25%4.83%
Aurobindo Pharma Limited1.19%4.59%
Glenmark Pharmaceuticals Limited0.88%3.42%
Alkem Laboratories Limited0.79%3.05%
Mankind Pharma Limited0.72%2.79%
IPCA Laboratories Limited0.69%2.65%
Biocon Limited0.63%2.42%
Ajanta Pharma Limited0.41%1.58%
Abbott India Limited0.34%1.32%

Sectors and company size

UTI Nifty Midcap 150 Exchange Traded FundNippon India Nifty Pharma ETF
Large companies5.8%45.3%
Mid companies90.6%47.1%
Small companies2.5%7.6%
Top 10 holdings18.3%78.6%
Largest sectorPharmaceuticals & Biotechnology 10%Pharmaceuticals & Biotechnology 100%

Search Growth